Guangxin Xia

474 total citations
30 papers, 331 citations indexed

About

Guangxin Xia is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Organic Chemistry. According to data from OpenAlex, Guangxin Xia has authored 30 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Organic Chemistry. Recurrent topics in Guangxin Xia's work include Hormonal Regulation and Hypertension (10 papers), Natural product bioactivities and synthesis (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Guangxin Xia is often cited by papers focused on Hormonal Regulation and Hypertension (10 papers), Natural product bioactivities and synthesis (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Guangxin Xia collaborates with scholars based in China, United States and Japan. Guangxin Xia's co-authors include Jianxin Yu, Jingkang Shen, Chenggang Huang, Bing Xiong, Yanjun Liu, Ping Li, Yu Mao, Jingshan Shen, Yanlian Li and Xinjian Chen and has published in prestigious journals such as Journal of Medicinal Chemistry, Molecules and European Journal of Medicinal Chemistry.

In The Last Decade

Guangxin Xia

29 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guangxin Xia China	12	187	101	46	39	36	30	331
Yongjun Li China	11	213 1.1×	121 1.2×	80 1.7×	18 0.5×	25 0.7×	26	404
Michał Chodyński Poland	12	117 0.6×	80 0.8×	58 1.3×	31 0.8×	13 0.4×	31	397
Shi-Wei Chao Taiwan	10	294 1.6×	40 0.4×	74 1.6×	44 1.1×	18 0.5×	10	449
Marinela Bostan Romania	13	185 1.0×	83 0.8×	74 1.6×	16 0.4×	17 0.5×	43	393
Shankar Jagadeesh United States	12	353 1.9×	63 0.6×	56 1.2×	14 0.4×	60 1.7×	18	537
Tomoyuki Fujioka Japan	10	166 0.9×	74 0.7×	28 0.6×	15 0.4×	24 0.7×	17	357
Nur Özten Kandaş Türkiye	13	130 0.7×	101 1.0×	27 0.6×	25 0.6×	26 0.7×	26	444
Gülseren Bağcı Türkiye	11	206 1.1×	43 0.4×	45 1.0×	16 0.4×	44 1.2×	36	411
Villayat Ali India	8	189 1.0×	32 0.3×	60 1.3×	31 0.8×	64 1.8×	19	379
Jacob Schwartzman United States	9	444 2.4×	56 0.6×	50 1.1×	21 0.5×	33 0.9×	15	551

Countries citing papers authored by Guangxin Xia

Since Specialization

Citations

This map shows the geographic impact of Guangxin Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangxin Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangxin Xia more than expected).

Fields of papers citing papers by Guangxin Xia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangxin Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangxin Xia. The network helps show where Guangxin Xia may publish in the future.

Co-authorship network of co-authors of Guangxin Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Guangxin Xia. A scholar is included among the top collaborators of Guangxin Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangxin Xia. Guangxin Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Yalong, Wei Zhou, Lei Wang, et al.. (2024). Synthesis and evaluation of homocamptothecin antibody-drug conjugates for cancer treatment. European Journal of Medicinal Chemistry. 279. 116899–116899.

Xie, Fei, Liping Li, Yumeng Hao, et al.. (2023). Discovery of novel triazoles containing benzyloxy phenyl isoxazole side chain with potent and broad-spectrum antifungal activity. Bioorganic Chemistry. 137. 106572–106572. 4 indexed citations

Xiang, Jinbao, Yuji Wang, Wanhe Wang, et al.. (2023). Design, synthesis, and pharmacological evaluation of quinazoline derivatives as novel and potent pan-JAK inhibitors. Bioorganic Chemistry. 140. 106765–106765. 6 indexed citations

Li, Di, Jiajia Xu, Na Chen, et al.. (2022). Discovery of SPH5030, a Selective, Potent, and Irreversible Tyrosine Kinase Inhibitor for HER2-Amplified and HER2-Mutant Cancer Treatment. Journal of Medicinal Chemistry. 65(7). 5334–5354. 8 indexed citations

Shan, Jing, et al.. (2021). Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SPH3127: A Phase I, Randomized, Double-Blind, Placebo-Controlled Trial. Clinical Therapeutics. 43(4). 735.e1–735.e14. 3 indexed citations

Wang, Qian, Xuemei Liao, Hui Ming Ge, et al.. (2020). Discovery of a novel series of imidazo[1′,2’:1,6]pyrido[2,3-d]pyrimidin derivatives as potent cyclin-dependent kinase 4/6 inhibitors. European Journal of Medicinal Chemistry. 193. 112239–112239. 16 indexed citations

Liao, Xuemei, Hong Yuan, Yu Mao, et al.. (2020). SPH3643: A novel cyclin‐dependent kinase 4/6 inhibitor with good anticancer efficacy and strong blood‐brain barrier permeability. Cancer Science. 111(5). 1761–1773. 16 indexed citations

Mao, Yu, Zhiwei Gao, Xiaoyan Chen, et al.. (2019). The Nonclinical Pharmacokinetics and Prediction of Human Pharmacokinetics of SPH3127, a Novel Direct Renin Inhibitor. European Journal of Drug Metabolism and Pharmacokinetics. 45(1). 15–26. 4 indexed citations

Mao, Yu, et al.. (2019). Evaluation of preclinical safety profile of SPH3127, a direct renin inhibitor, after 28-day repeated oral administration in Sprague-Dawley rats and cynomolgus monkeys. Regulatory Toxicology and Pharmacology. 109. 104484–104484. 2 indexed citations

10.

Chen, Shi, Qian Wang, Xuemei Liao, et al.. (2019). Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancer. European Journal of Medicinal Chemistry. 178. 352–364. 20 indexed citations

11.

Zhao, Fei, Hao Yu, Rui Bai, et al.. (2017). Identification of 3-substituted-6-(1-(1 H -[1,2,3]triazolo[4,5- b ]pyrazin-1-yl)ethyl)quinoline derivatives as highly potent and selective mesenchymal-epithelial transition factor (c-Met) inhibitors via metabolite profiling-based structural optimization. European Journal of Medicinal Chemistry. 134. 147–158. 18 indexed citations

12.

Zhao, Fei, Jing Zhang, Yu Hao, et al.. (2016). Discovery and optimization of a series of imidazo[4,5-b]pyrazine derivatives as highly potent and exquisitely selective inhibitors of the mesenchymal–epithelial transition factor (c-Met) protein kinase. Bioorganic & Medicinal Chemistry. 24(18). 4281–4290. 17 indexed citations

13.

Xia, Guangxin, Lin Liu, Haiyan Liu, et al.. (2013). Design and Synthesis of (R)‐1‐Arylsulfonylpiperidine‐2‐carboxamides as 11β‐Hydroxysteroid Dehydrogenase Type 1 Inhibitors. ChemMedChem. 8(4). 577–581. 6 indexed citations

14.

Xia, Guangxin, Lin Liu, Haiyan Liu, et al.. (2013). Design, synthesis and SAR of piperidyl-oxadiazoles as 11β-hydroxysteroid dehydrogenase 1 inhibitors. European Journal of Medicinal Chemistry. 62. 1–10. 11 indexed citations

15.

Xia, Guangxin, Lin Liu, Mengzhu Xue, et al.. (2012). Discovery of novel sulfonamides as potent and selective inhibitors against human and mouse 11β-hydroxysteroid dehydrogenase type 1. Molecular and Cellular Endocrinology. 358(1). 46–52. 10 indexed citations

16.

Xia, Guangxin, Mengzhu Xue, Lin Liu, et al.. (2011). Potent and novel 11β-HSD1 inhibitors identified from shape and docking based virtual screening. Bioorganic & Medicinal Chemistry Letters. 21(19). 5739–5744. 14 indexed citations

17.

Tang, Yihong, et al.. (2010). Characterization of anti‐Coxsackie virus B3 constituents of Radix Astragali by high‐performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry. Biomedical Chromatography. 24(11). 1147–1151. 11 indexed citations

18.

Ye, Guan, Yanling Yang, Guangxin Xia, Mingsong Fan, & Chenggang Huang. (2008). Complete NMR spectral assignments of two new iridoid diastereoisomers from the flowers of Plumeria rubra L. cv. acutifolia. Magnetic Resonance in Chemistry. 46(12). 1195–1197. 14 indexed citations

19.

Xia, Guangxin, et al.. (2008). Determination of two metabolites of calycosin‐7‐O‐β‐d‐glucopyranoside in rat urine by HPLC. Biomedical Chromatography. 23(1). 48–53. 4 indexed citations

20.

Xia, Guangxin, Jianfeng Li, Shujun Zhang, et al.. (2005). Synthesis and phosphodiesterase 5 inhibitory activity of novel pyrido[1,2-e]purin-4(3H)-one derivatives. Bioorganic & Medicinal Chemistry Letters. 15(11). 2790–2794. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact